Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
+8.89M
-
Total reported value, excl. options
-
$546M
-
Value change
-
+$279M
-
Number of buys
-
18
-
Number of sells
-
-28
-
Price
-
$30.66
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q3 2018
53 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q3 2018.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 23.6M outstanding shares and own 75.6% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (10.8M shares), Cormorant Asset Management, LP (1.33M shares), Polygon Management Ltd. (790K shares), Alphabet Inc. (714K shares), Capital World Investors (611K shares), PRICE T ROWE ASSOCIATES INC /MD/ (503K shares), Artal Group S.A. (500K shares), Capital International Investors (489K shares), SPHERA FUNDS MANAGEMENT LTD. (296K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (250K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.